The authors determined the frequency of PALB2 monoallelic truncating variants in a familial breast cancer cohort negative for BRCA mutations (10/923, 1.1%), which was far more common than in controls (0/1,084, 0%; p = 0.0004). The gene discussed is PALB2; the disease is breast cancer.